Louise Locock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Louise Locock has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Ann McPherson
DIPEx Research Group, Department of Primary Care, Old Rd Campus, University of Oxford, Headington, Oxford OX3 7LF, UK
1 shared publicationAnnette Boaz
ESRC Centre for Evidence Based Policy and Practice Queen Mary, University of London
1 shared publicationCarol Dumelow
Freelance Researcher
1 shared publicationJane Crawford
1 shared publicationJanice B. Brown
University of Southampton, UK
1 shared publicationJo Alexander
1 shared publication
Latest Publications
- 16 December 2010
- Published by SAGE Publications in Clinical Trials
- Vol. 8 (1) , 85-93
Personal benefit, or benefiting others? Deciding whether to take part in clinical trials
Background Participation in clinical trials is critical for the success of evidence-based healthcare. Much previous research suggests that people take part in clinical trials mostly for altruistic reasons, and that deriving personal benefit is a secondary consideration.
- 16 December 2010
- Published by SAGE Publications in Clinical Trials
- Vol. 8 (1) , 85-93
Personal benefit, or benefiting others? Deciding whether to take part in clinical trials
Background Participation in clinical trials is critical for the success of evidence-based healthcare. Much previous research suggests that people take part in clinical trials mostly for altruistic reasons, and that deriving personal benefit is a secondary consideration.
- 1 October 2010
- Published by Elsevier in Social Science & Medicine
- Vol. 71 (8) , 1498-1505
‘All in the same boat’? Patient and carer attitudes to peer support and social comparison in Motor Neurone Disease (MND)
- 1 October 2010
- Published by Elsevier in Social Science & Medicine
- Vol. 71 (8) , 1498-1505
‘All in the same boat’? Patient and carer attitudes to peer support and social comparison in Motor Neurone Disease (MND)
- Open Access
- 22 October 2009
- Published by Wiley in Sociology of Health & Illness
- Vol. 31 (7) , 1043-1058
Biographical disruption, abruption and repair in the context of Motor Neurone Disease
Concepts of biographical disruption and repair have been widely applied to chronic illness, but not terminal illness. This paper examines the relevance of these concepts to motor neurone disease (MND), a progressive neurological condition characterised by loss of mobility, speech and ability to breathe or swallow. Survival is usually between two and five years, and some die within a few months. The condition thus lies at the boundary between chronic and terminal illness. Narrative interviews were conducted with 35 people living with MND and 11 family carers; analysis exploredhowpeople constructed their accounts as well aswhatthey said. As well as accounts of biographical disruption, we identified a distinctive sense that the diagnosis is a ‘death sentence’ and life is already over, which we term ‘biographical abruption’. We also found instances of biographical repair, as participants sought to make sense of their remaining life, restore normality and control, and find new meaning and identity.
- 22 October 2009
- Published by Wiley in Sociology of Health & Illness
- Vol. 31 (7) , 1043-1058
Open AccessBiographical disruption, abruption and repair in the context of Motor Neurone Disease
Concepts of biographical disruption and repair have been widely applied to chronic illness, but not terminal illness. This paper examines the relevance of these concepts to motor neurone disease (MND), a progressive neurological condition characterised by loss of mobility, speech and ability to breathe or swallow. Survival is usually between two and five years, and some die within a few months. The condition thus lies at the boundary between chronic and terminal illness. Narrative interviews were conducted with 35 people living with MND and 11 family carers; analysis exploredhowpeople constructed their accounts as well aswhatthey said. As well as accounts of biographical disruption, we identified a distinctive sense that the diagnosis is a ‘death sentence’ and life is already over, which we term ‘biographical abruption’. We also found instances of biographical repair, as participants sought to make sense of their remaining life, restore normality and control, and find new meaning and identity.
- 1 March 2008
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 58 (548) , 161-168
Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era
England is the only country in the world that currently has universal population screening for haemoglobin disorders through linked antenatal and newborn screening. Little is known about the acceptability of such screening. To explore parents' experiences of, and attitudes towards, new universal genetic screening for haemoglobin disorders. Narrative interview study. Primary and community care settings across England. Narrative interviews were undertaken with a maximum variation sample of 39 people who had experienced gene-carrier identification through antenatal and newborn screening for sickle cell, thalassaemia, and other haemoglobin variants within the previous 2 years. Most parents were unaware screening had occurred or had given it little consideration and so were surprised or shocked by results. However, they were glad to learn of their carrier status, reproductive genetic risk, or their newborn's carrier status. Participants emphasised that antenatal screening should happen as early as possible. Many would rather have known their carrier status before pregnancy or before entering a relationship. Although most were satisfied with the information they received, significant misunderstandings remained. There were culturally diverse attitudes towards prenatal diagnosis and termination. These procedures were acceptable to some parents with strong religious beliefs, including Christians and Muslims. Parents support screening for haemoglobin disorders but need to be better informed and better prepared for results and what they mean. Sensitivity to patient diversity in attitudes and choices is also required. Universal screening for genetic reproductive risk will increasingly involve generalists, particularly in primary care, presenting opportunities for screening before or earlier in pregnancy, which is likely to be welcomed by patients.
- 1 March 2008
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 58 (548) , 161-168
Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era
England is the only country in the world that currently has universal population screening for haemoglobin disorders through linked antenatal and newborn screening. Little is known about the acceptability of such screening. To explore parents' experiences of, and attitudes towards, new universal genetic screening for haemoglobin disorders. Narrative interview study. Primary and community care settings across England. Narrative interviews were undertaken with a maximum variation sample of 39 people who had experienced gene-carrier identification through antenatal and newborn screening for sickle cell, thalassaemia, and other haemoglobin variants within the previous 2 years. Most parents were unaware screening had occurred or had given it little consideration and so were surprised or shocked by results. However, they were glad to learn of their carrier status, reproductive genetic risk, or their newborn's carrier status. Participants emphasised that antenatal screening should happen as early as possible. Many would rather have known their carrier status before pregnancy or before entering a relationship. Although most were satisfied with the information they received, significant misunderstandings remained. There were culturally diverse attitudes towards prenatal diagnosis and termination. These procedures were acceptable to some parents with strong religious beliefs, including Christians and Muslims. Parents support screening for haemoglobin disorders but need to be better informed and better prepared for results and what they mean. Sensitivity to patient diversity in attitudes and choices is also required. Universal screening for genetic reproductive risk will increasingly involve generalists, particularly in primary care, presenting opportunities for screening before or earlier in pregnancy, which is likely to be welcomed by patients.
- 1 March 2006
- Published by Elsevier in Social Science & Medicine
- Vol. 62 (6) , 1349-1359
‘Just a bystander’? Men's place in the process of fetal screening and diagnosis
- 1 March 2006
- Published by Elsevier in Social Science & Medicine
- Vol. 62 (6) , 1349-1359
‘Just a bystander’? Men's place in the process of fetal screening and diagnosis
The parents' journey: continuing a pregnancy after a diagnosis of Patau's syndrome
Introduction Patau's syndrome (trisomy 13) is a rare condition, associated with high mortality, a range of congenital abnormalities, and severe physical and cognitive impairment. Many affected pregnancies will miscarry, and most babies born with the condition will not survive more than a few days or weeks. Less than 10% of babies with the condition will survive their first year of life.1 Parents who discover during pregnancy that their baby has a serious chromosomal condition such as Patau's syndrome suddenly find themselves on an unexpected journey away from their hopes for a healthy baby and a normal family life towards a new and challenging situation. Many parents in this situation will decide to end the pregnancy, but a few will decide to continue. This is the story of one couple who discovered at the 20 week scan that their baby had Patau's syndrome, and decided to go ahead with the pregnancy. Baby Benjamin was born at 35 weeks and lived for three minutes after birth. Much of the story is told in the couple's own words, recorded in an interview three months after the baby's death. This article draws on interview data collected in 2003-4 for a wider research project on experiences of antenatal screening, now part of the DIPEx website collection (personal experiences of health and illness; see www.dipex.org/antenatalscreening for other findings and video clips from the interviews). This research included people who had routine screening experiences as well as parents of babies diagnosed with a variety of conditions, some of whom decided to end the pregnancy and some to continue.
The parents' journey: continuing a pregnancy after a diagnosis of Patau's syndrome
Introduction Patau's syndrome (trisomy 13) is a rare condition, associated with high mortality, a range of congenital abnormalities, and severe physical and cognitive impairment. Many affected pregnancies will miscarry, and most babies born with the condition will not survive more than a few days or weeks. Less than 10% of babies with the condition will survive their first year of life.1 Parents who discover during pregnancy that their baby has a serious chromosomal condition such as Patau's syndrome suddenly find themselves on an unexpected journey away from their hopes for a healthy baby and a normal family life towards a new and challenging situation. Many parents in this situation will decide to end the pregnancy, but a few will decide to continue. This is the story of one couple who discovered at the 20 week scan that their baby had Patau's syndrome, and decided to go ahead with the pregnancy. Baby Benjamin was born at 35 weeks and lived for three minutes after birth. Much of the story is told in the couple's own words, recorded in an interview three months after the baby's death. This article draws on interview data collected in 2003-4 for a wider research project on experiences of antenatal screening, now part of the DIPEx website collection (personal experiences of health and illness; see www.dipex.org/antenatalscreening for other findings and video clips from the interviews). This research included people who had routine screening experiences as well as parents of babies diagnosed with a variety of conditions, some of whom decided to end the pregnancy and some to continue.
- 1 July 2004
- Published by Cambridge University Press (CUP) in Social Policy and Society
- Vol. 3 (4) , 375-384
Research, Policy and Practice – Worlds Apart?
The relationship between research, policy and practice remains a contested area. This article explores pressures for researchers to make their work more useful and relevant to policy and practice, and for practitioners to undertake research. Whilst there are clearly areas of mutual interest and benefit, we argue that the research, policy and practice communities also have distinct traditions, skills and obligations which should be recognised and valued rather than artificially suppressed. Narrow conceptions of research utility constrain the debate about what each community has to offer and how best to communicate with each other across borders.
- 1 July 2004
- Published by Cambridge University Press (CUP) in Social Policy and Society
- Vol. 3 (4) , 375-384
Research, Policy and Practice – Worlds Apart?
The relationship between research, policy and practice remains a contested area. This article explores pressures for researchers to make their work more useful and relevant to policy and practice, and for practitioners to undertake research. Whilst there are clearly areas of mutual interest and benefit, we argue that the research, policy and practice communities also have distinct traditions, skills and obligations which should be recognised and valued rather than artificially suppressed. Narrow conceptions of research utility constrain the debate about what each community has to offer and how best to communicate with each other across borders.